Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Audrey Thomas-Schoemann

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Oncoimmunology|June 27, 2013
A new strategy to target regulatory T cells in solid tumorsAudrey Thomas-Schoemann, Frédéric Batteux, Jérôme Alexandre
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 10, 2024
Letter to the editor regarding the paper by A. Boileve et al.: Safety of direct oral anticoagulants in patients with advanced solid tumors receiving anti‑VEGF agents: a retrospective studyTinhinane Inouri, Johanna Noel, Benoît Blanchet, et al.
Bulletin Du Cancer|June 4, 2011
[Use of antioxidant and other complementary medicine by patients treated by antitumor chemotherapy: a prospective study]Audrey Thomas-Schoemann, Jérôme Alexandre, Céline Mongaret, et al.
Critical Reviews in Oncology/Hematology|September 18, 2013
Drug interactions with solid tumour-targeted therapiesAudrey Thomas-Schoemann, Benoit Blanchet, Christophe Bardin, et al.
Critical Reviews in Oncology/Hematology|August 12, 2018
Pharmacokinetic variability of anticoagulants in patients with cancer-associated thrombosis: Clinical consequencesAudrey Bellesoeur, Audrey Thomas-Schoemann, Marie Allard, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 28, 2015
A HPLC-fluorescence method for the quantification of abiraterone in plasma from patients with metastatic castration-resistant prostate cancerTiphaine Belleville, Gaëlle Noé, Olivier Huillard, et al.
Cancer Chemotherapy and Pharmacology|November 21, 2013
Fractionation of daily dose increases the predicted risk of severe sorafenib-induced hand-foot syndrome (HFS)Emilie Hénin, Benoit Blanchet, Pascaline Boudou-Rouquette, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 5, 2017
ADAM9 expression promotes an aggressive lung adenocarcinoma phenotypeCéline Mongaret Kossmann, Maxime Annereau, Audrey Thomas-Schoemann, et al.
Endocrine Connections|December 12, 2018
Pharmacokinetic interaction between mitotane and etoposide in adrenal carcinoma: a pilot studyAnne Jouinot, Bernard Royer, Etienne Chatelut, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 23, 2013
An HPLC-UV method for the simultaneous quantification of vemurafenib and erlotinib in plasma from cancer patientsYi Zhen, Audrey Thomas-Schoemann, Lilia Sakji, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Oncoimmunology|June 27, 2013
A new strategy to target regulatory T cells in solid tumorsAudrey Thomas-Schoemann, Frédéric Batteux, Jérôme Alexandre
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 10, 2024
Letter to the editor regarding the paper by A. Boileve et al.: Safety of direct oral anticoagulants in patients with advanced solid tumors receiving anti‑VEGF agents: a retrospective studyTinhinane Inouri, Johanna Noel, Benoît Blanchet, et al.
Bulletin Du Cancer|June 4, 2011
[Use of antioxidant and other complementary medicine by patients treated by antitumor chemotherapy: a prospective study]Audrey Thomas-Schoemann, Jérôme Alexandre, Céline Mongaret, et al.
Critical Reviews in Oncology/Hematology|September 18, 2013
Drug interactions with solid tumour-targeted therapiesAudrey Thomas-Schoemann, Benoit Blanchet, Christophe Bardin, et al.
Critical Reviews in Oncology/Hematology|August 12, 2018
Pharmacokinetic variability of anticoagulants in patients with cancer-associated thrombosis: Clinical consequencesAudrey Bellesoeur, Audrey Thomas-Schoemann, Marie Allard, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 28, 2015
A HPLC-fluorescence method for the quantification of abiraterone in plasma from patients with metastatic castration-resistant prostate cancerTiphaine Belleville, Gaëlle Noé, Olivier Huillard, et al.
Cancer Chemotherapy and Pharmacology|November 21, 2013
Fractionation of daily dose increases the predicted risk of severe sorafenib-induced hand-foot syndrome (HFS)Emilie Hénin, Benoit Blanchet, Pascaline Boudou-Rouquette, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 5, 2017
ADAM9 expression promotes an aggressive lung adenocarcinoma phenotypeCéline Mongaret Kossmann, Maxime Annereau, Audrey Thomas-Schoemann, et al.
Endocrine Connections|December 12, 2018
Pharmacokinetic interaction between mitotane and etoposide in adrenal carcinoma: a pilot studyAnne Jouinot, Bernard Royer, Etienne Chatelut, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 23, 2013
An HPLC-UV method for the simultaneous quantification of vemurafenib and erlotinib in plasma from cancer patientsYi Zhen, Audrey Thomas-Schoemann, Lilia Sakji, et al.
Pageof 5